
    
      This is a prospective, randomized, single center study. Patients scheduled for CABG will be
      screened and enrolled. Subjects positive for heparin/PF4 antibody within 24 h after CABG and
      without clinical suspicion of HIT will be randomized into one of two groups. An additional 30
      patients with negative antibody titers will serve as a control group.
    
  